Study Title and Description
Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.|
|Author||Cibrik D., Meier-Kriesche HU., Bresnahan B., Wu YM., Klintmalm G., Kew CE., Kuo PC., Whelchel J., Cohen D., Baliga P., Akalin E., Benedetti E., Wright F., Lieberman B., Ulbricht B., Jensik S.|
|Country||Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI 48109, USA. email@example.com|
|Year||-- Not Found --|
Pubmed ID: 17425744
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.